To degrade the mutant huntingtin (mHTT) in Huntington’s disease, Li et al. [32] identified four promising ATTEC candidates—10O5 (GW5074), 8F20 (ispinesib), AN1, and AN2—through small molecule microarray screening of 3375 compounds. Here, PAX6 is linked to juvenile Huntington disease.